Additional file 4: Figure S2. of Cancer network activity associated with therapeutic response and synergism Serra-MusachJordi MateoFrancesca Capdevila-BusquetsEva de GaribayGorka ZhangXiaohu GuhaRaj ThomasCraig GruesoJudit VillanuevaAlberto JaegerSamira HeynHolger VizosoMiguel PérezHector CorderoAlex Gonzalez-SuarezEva EstellerManel Moreno-BuenoGema TjärnbergAndreas LázaroConxi SerraVioleta ArribasJoaquín BensonMikael GustafssonMika FerrerMarc AloyPatrick PujanaMiquel 2016 Corroboration of CNA-IC50 correlations using a high-quality interactome dataset. The PCC distribution difference between drugs that target CTKs or STKs is maintained when the network is based on a high-quality dataset derived from the combination of reliable literature-curated binary interactions and well-verified high-throughput yeast two-hybrid interactions. (PDF 162 kb)